Apical membrane antigen 1 as an anti-malarial drug target

Christopher MacRaild, Robin Anders, Michael Foley, Raymond Norton

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The invasion of host cells by malaria parasites represents an attractive target for therapeutic intervention. The role played by apical membrane antigen 1 (AMA1) in this process has been elucidated recently with the demonstration that AMA1 forms a complex with parasite rhoptry neck (RON) proteins as part of the moving junction that develops between the host cell and the invading parasite. Structural studies of AMA1 alone and in complexes with antibodies that inhibit host cell invasion have identified a conserved hydrophobic cleft that is essential to the assembly of the AMA1/RON complex. AMA1 is already established as an important candidate for inclusion in a malaria vaccine. Here we review both the structural details and functional significance of interactions at the hydrophobic cleft of AMA1, and argue that this feature of the protein represents an excellent target for the development of drugs that would block host cell invasion by malarial parasites.
Original languageEnglish
Pages (from-to)2039 - 2047
Number of pages9
JournalCurrent Topics in Medicinal Chemistry
Volume11
Issue number16
DOIs
Publication statusPublished - 2011

Cite this

@article{cfd287242bc94bc1bed062c60b0a51f6,
title = "Apical membrane antigen 1 as an anti-malarial drug target",
abstract = "The invasion of host cells by malaria parasites represents an attractive target for therapeutic intervention. The role played by apical membrane antigen 1 (AMA1) in this process has been elucidated recently with the demonstration that AMA1 forms a complex with parasite rhoptry neck (RON) proteins as part of the moving junction that develops between the host cell and the invading parasite. Structural studies of AMA1 alone and in complexes with antibodies that inhibit host cell invasion have identified a conserved hydrophobic cleft that is essential to the assembly of the AMA1/RON complex. AMA1 is already established as an important candidate for inclusion in a malaria vaccine. Here we review both the structural details and functional significance of interactions at the hydrophobic cleft of AMA1, and argue that this feature of the protein represents an excellent target for the development of drugs that would block host cell invasion by malarial parasites.",
author = "Christopher MacRaild and Robin Anders and Michael Foley and Raymond Norton",
year = "2011",
doi = "10.2174/156802611796575885",
language = "English",
volume = "11",
pages = "2039 -- 2047",
journal = "Current Topics in Medicinal Chemistry",
issn = "1568-0266",
publisher = "Bentham Science Publishers",
number = "16",

}

Apical membrane antigen 1 as an anti-malarial drug target. / MacRaild, Christopher; Anders, Robin; Foley, Michael; Norton, Raymond.

In: Current Topics in Medicinal Chemistry, Vol. 11, No. 16, 2011, p. 2039 - 2047.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Apical membrane antigen 1 as an anti-malarial drug target

AU - MacRaild, Christopher

AU - Anders, Robin

AU - Foley, Michael

AU - Norton, Raymond

PY - 2011

Y1 - 2011

N2 - The invasion of host cells by malaria parasites represents an attractive target for therapeutic intervention. The role played by apical membrane antigen 1 (AMA1) in this process has been elucidated recently with the demonstration that AMA1 forms a complex with parasite rhoptry neck (RON) proteins as part of the moving junction that develops between the host cell and the invading parasite. Structural studies of AMA1 alone and in complexes with antibodies that inhibit host cell invasion have identified a conserved hydrophobic cleft that is essential to the assembly of the AMA1/RON complex. AMA1 is already established as an important candidate for inclusion in a malaria vaccine. Here we review both the structural details and functional significance of interactions at the hydrophobic cleft of AMA1, and argue that this feature of the protein represents an excellent target for the development of drugs that would block host cell invasion by malarial parasites.

AB - The invasion of host cells by malaria parasites represents an attractive target for therapeutic intervention. The role played by apical membrane antigen 1 (AMA1) in this process has been elucidated recently with the demonstration that AMA1 forms a complex with parasite rhoptry neck (RON) proteins as part of the moving junction that develops between the host cell and the invading parasite. Structural studies of AMA1 alone and in complexes with antibodies that inhibit host cell invasion have identified a conserved hydrophobic cleft that is essential to the assembly of the AMA1/RON complex. AMA1 is already established as an important candidate for inclusion in a malaria vaccine. Here we review both the structural details and functional significance of interactions at the hydrophobic cleft of AMA1, and argue that this feature of the protein represents an excellent target for the development of drugs that would block host cell invasion by malarial parasites.

UR - http://www.scopus.com/record/display.url?eid=2-s2.0-80051699901&origin=inward&txGid=UBgHCQAe2SdjC81LNQQPruE%3a7

U2 - 10.2174/156802611796575885

DO - 10.2174/156802611796575885

M3 - Article

VL - 11

SP - 2039

EP - 2047

JO - Current Topics in Medicinal Chemistry

JF - Current Topics in Medicinal Chemistry

SN - 1568-0266

IS - 16

ER -